Zofluza intermediate
|
|
Zofluza intermediate 속성
- 끓는 점
- 379.5±42.0 °C(Predicted)
- 밀도
- 1.400±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 12.57±0.20(Predicted)
- InChI
- InChI=1S/C14H10F2OS/c15-11-6-5-8-10(13(11)16)7-18-12-4-2-1-3-9(12)14(8)17/h1-6,14,17H,7H2
- InChIKey
- OBEXFUFBCNVOKB-UHFFFAOYSA-N
- SMILES
- S1CC2=C(F)C(F)=CC=C2C(O)C2=CC=CC=C12
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
| 그림문자(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 신호 어: | Warning | |||||||||||||||||||||||||||||||||||
| 유해·위험 문구: |
|
|||||||||||||||||||||||||||||||||||
| 예방조치문구: |
|
Zofluza intermediate 공급 업체
글로벌( 258)공급 업체
| 공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
|---|---|---|---|---|---|
| Heading （Nanjing）Pharmtechnologies Co., Ltd. | +86-25-58467899-832 +86-13382406280 |
liucheng@headingpharm.com | China | 46 | 58 |
| Senova Technology Co. Ltd. | +86-0755-86703119 +8618503098836 |
info@senovatech.com | China | 351 | 58 |
| Cangzhou Kangrui Pharma Tech Co. Ltd., | +8618632776803 |
cangzhoukangrui@126.com | China | 733 | 58 |
| Hebei Mojin Biotechnology Co., Ltd | +86 13288715578 +8613288715578 |
sales@hbmojin.com | China | 12495 | 58 |
| Hangzhou ICH Biofarm Co., Ltd | +86-0571-28186870; +undefined8613073685410 |
sales@ichemie.com | China | 990 | 58 |
| Hebei Xinsheng New Material Technology Co., LTD. | +86-16632316109 |
xinshengkeji@xsmaterial.com | China | 1090 | 58 |
| hebei hongtan Biotechnology Co., Ltd | +86-86-1913198-3935 +8617331935328 |
sales03@chemcn.cn | China | 973 | 58 |
| Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 |
sales@capotchem.com | China | 29798 | 60 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21663 | 55 |
| Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 |
fandachem@gmail.com | China | 9284 | 55 |
Zofluza intermediate 관련 검색:
Baloxavir marboxil
Baloxavir Impurity 5
Baloxavir
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
BAY 299
T-26c
AZD-7594
4-[4-(1-methyl-1H-pyrazol-4-yl)-1-[2-(1-methyl-1H-pyrazol-4-yl)ethyl]-1H-imidazol-5-yl]-benzonitrile
ABBV-744
RGX-104 HCl
Adavivint
4H-Pyran-2-carboxaldehyde, 4-oxo-3-(phenylmethoxy)-
3-(BENZYLOXY)-2-METHYL-4H-PYRAN-4-ONE
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Zoledronic acid
7,8-difluorodibenzo[b,e]thiepin-11(6H)-one
1-amino-3-(benzyloxy)-4-oxo-N-(2-(2-oxoethoxy)ethyl)-1,4-dihydropyridine-2-carboxamide